tirzepatide mechanism of action vs semaglutide for Weight Loss: Which Drug Delivers Better Results? Tirzepatide vs Semaglutide: Key Differences

Because of their intermittent stimulation of the GLP-1R, short-acting GLP-1RAs retain their ability to delay gastric emptying leading to lower postprandial glucose excursions compared with the long-acting GLP-1RAs, which are associated with the development of tolerance (tachyphylaxis) to GLP-1s effect on gastric emptying (10)

You probably already know that GLP-1 medications suppress appetite, but did you know that they are known to suppress thirst too

JackelMerrill Wealth ManagementNew YorkNew York - NYC (High Net Worth)$1M$1.2B$2.5-10M$2-8MAngel ValleUBS Wealth ManagementNew YorkNew York - NYC (High Net Worth)$2M$333M$3-40M$2-3MJess CrespiJ.P

Acceptable Documentation Sources Medication reconciliation list showing insulin as an active current medication Provider note explicitly stating patient is on long-term insulin therapy or insulin-controlled Type 2 diabetes Prescription record for insulin within the encounter date or active medication review Problem list entry indicating insulin-dependent or insulin-controlled diabetes What Documentation Is Insufficient A history of insulin use without confirmation it is ongoing at this encounter A notation that insulin was administered during the encounter without evidence of an ongoing regimen Discharge summary from a prior hospitalization only, with no current medication confirmation Practices that use digital intake forms can embed medication status prompts that capture insulin use at every visit check-in, creating a structured data point in the record without requiring the provider to manually note it in the encounter documentation

[15] NICE focuses instead on clinical eligibility criteria, monitoring requirements, and the importance of adjunctive lifestyle intervention

Glucagon-Like Peptide-1 Receptor Agonists Across the Spectrum of Heart Failure